Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服水仙素是不恰当的，很少有炎症能超过急性足痛风的病人了，水仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受水仙碱效果不明显转而受氨苯的患者应当继续服用水仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服素是不恰当的，很少有炎症急性足痛风的病人了，并且素导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受碱治疗效果不明显转而受氨苯砜治疗的患者应当继续服用碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋水仙素是不恰当，有炎症能超过急性足痛风病人了，并且秋水仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受秋水仙碱治疗效果不明显转而受氨苯砜治疗患者应当继续服用秋水仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋水仙素是不恰当，很少有炎症能超过急性足痛风，并且秋水仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受秋水仙碱治疗效果不明显转而受氨苯砜治疗应当继续服用秋水仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

秋水仙素是不恰当的，很少有炎症能超过急性足痛风的病人了，并且秋水仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受秋水仙碱治疗效果不明显转而受氨苯砜治疗的患者应当继续用秋水仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋水仙素是不恰当，很少有炎症能超过急性足痛风病，且秋水仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受秋水仙碱治效果不明显转而受氨苯砜治者应当继续服用秋水仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋水仙素是不恰当的，很少有炎症能超过急性足痛风的病人了，并且秋水仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受秋水仙碱治疗效果不明显转而受氨苯砜治疗的患者应当继续服用秋水仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服素是不恰当的，很少有炎症急性足痛风的病人了，并且素导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受碱治疗效果不明显转而受氨苯砜治疗的患者应当继续服用碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋水仙素是不恰当，有炎症能超过急性足痛风病人了，并且秋水仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受秋水仙碱治疗效果不明显转而受氨苯砜治疗患者应当继续服用秋水仙碱。